Discover 1,255 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,255
Active & Responsive
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
for
Non-segmental Vitiligo
Location: Murfreesboro TN, Birmingham AL, Indianapolis IN,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07431177
Phase2, Recruiting
Active & Responsive
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
for
Psoriatic Arthritis, Axial Spondyloarthritis
Location: Murfreesboro TN, Jackson TN, Vandalia OH, Rock Hill SC,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 18+
Code: NCT07290036
Phase1, Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Smyrna TN, Bowling Green KY, Douglasville GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Active & Responsive
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
for
Obesity, Overweight and/or Obesity, Overweight,
Location: La Vergne TN, Goodlettsville TN, Atlanta GA, Decatur GA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07400653
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Franklin TN, Huntsville AL, Marietta GA, Cincinnati OH,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase2, Recruiting
Active & Responsive
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for
Major Depressive Disorder
Location: Franklin TN, Stone Mountain GA, Metairie LA, Chicago IL,
Sponsor: Syndeio Biosciences, Inc
Sex: All
Age: 18 - 64
Code: NCT07115329
Phase2, Recruiting
Active & ResponsiveNew
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight